2023 Survey: Automation Is Ubiquitous for Orphan and Specialty Drug Commercialization
87% of Biopharma Respondents Use AI/ML for Post-Market Activities, But Key Missed Opportunities...
Posts about
Technology
Using ML/AI to Find the Right Patients at the Right Time: A Conversation with AVEO Oncology
By: John Seaner, CMO, IPM.ai/Swoop
Ganesh Rajaratnam, Senior Director of Commercial Operations,...
Building a Rare Disease Franchise with Machine Learning and Artificial Intelligence
By: John Seaner, CMO, IPM.ai/Swoop
Nitin Choudhary, Managing Principal of IPM.ai and Richard...
IPM.ai's Clinical Trial Recruitment Solution Featured in MM&M
By: John Seaner, CMO, IPM.ai/Swoop
Allison Rhee of MM&M reports on IPM.ai's answer to patient...
Kyowa Kirin Uses AI/ML to Uncover Undiagnosed Patients
By: John Seaner, CMO, IPM.ai/Swoop
The rare disease patient journey can be arduous. Many patients...
John Garcia of Alnylam Discusses Finding Patients With Rare Disease
By: John Seaner, CMO, IPM.ai/Swoop
Challenges are an inevitability when building a drug portfolio...
Using ML and AI to Infer HCP Specialties
By: John Seaner, CMO, IPM.ai/Swoop
Specialty Physician Identification: Your Best Targets Could Be...